190 related articles for article (PubMed ID: 33148505)
21. Rapporteur's Report Session 6: risk assessment of asbestos and other fibrous mineral particulates.
Nolan RP; Langer AM
Regul Toxicol Pharmacol; 2008 Oct; 52(1 Suppl):S246-8. PubMed ID: 18585424
[No Abstract] [Full Text] [Related]
22. Dimensional characteristics of the major types of amphibole mineral particles and the implications for carcinogenic risk assessment.
Korchevskiy AA; Wylie AG
Inhal Toxicol; 2022; 34(1-2):24-38. PubMed ID: 35001771
[No Abstract] [Full Text] [Related]
23. A case-control study of mesothelioma in Minnesota iron ore (taconite) miners.
Lambert CS; Alexander BH; Ramachandran G; MacLehose RF; Nelson HH; Ryan AD; Mandel JH
Occup Environ Med; 2016 Feb; 73(2):103-9. PubMed ID: 26655961
[TBL] [Abstract][Full Text] [Related]
24. Methodologies for determining the sources, characteristics, distribution, and abundance of asbestiform and nonasbestiform amphibole and serpentine in ambient air and water.
Wylie AG; Candela PA
J Toxicol Environ Health B Crit Rev; 2015; 18(1):1-42. PubMed ID: 25825806
[TBL] [Abstract][Full Text] [Related]
25. Dimensional determinants for the carcinogenic potency of elongate amphibole particles.
Korchevskiy AA; Wylie AG
Inhal Toxicol; 2021; 33(6-8):244-259. PubMed ID: 34612763
[TBL] [Abstract][Full Text] [Related]
26. Asbestos-related disease associated with exposure to asbestiform tremolite.
Srebro SH; Roggli VL
Am J Ind Med; 1994 Dec; 26(6):809-19. PubMed ID: 7892832
[TBL] [Abstract][Full Text] [Related]
27. Toxicological and epidemiological approaches to carcinogenic potency modeling for mixed mineral fiber exposure: the case of fibrous balangeroite and chrysotile.
Korchevskiy AA; Wylie AG
Inhal Toxicol; 2023; 35(7-8):185-200. PubMed ID: 37220304
[TBL] [Abstract][Full Text] [Related]
28. The relationship between various exposure metrics for elongate mineral particles (EMP) in the taconite mining and processing industry.
Hwang J; Ramachandran G; Raynor PC; Alexander BH; Mandel JH
J Occup Environ Hyg; 2014; 11(9):613-24. PubMed ID: 24512074
[TBL] [Abstract][Full Text] [Related]
29. A Critique of Helsinki Criteria for Using Lung Fiber Levels to Determine Causation in Mesothelioma Cases.
Tran T; Egilman D; Rigler M; Emory T
Ann Glob Health; 2021; 87(1):73. PubMed ID: 34395196
[TBL] [Abstract][Full Text] [Related]
30. Evaluation of the presence of asbestos in cosmetic talcum products.
Pierce JS; Riordan AS; Miller EW; Gaffney SH; Hollins DM
Inhal Toxicol; 2017 Aug; 29(10):443-456. PubMed ID: 29124998
[TBL] [Abstract][Full Text] [Related]
31. The epidemiologic evidence for elongate mineral particle (EMP)-related human cancer risk.
Boffetta P; Mundt KA; Thompson WJ
Toxicol Appl Pharmacol; 2018 Dec; 361():100-106. PubMed ID: 30240694
[TBL] [Abstract][Full Text] [Related]
32. An inter-laboratory study to determine the effectiveness of procedures for discriminating amphibole asbestos fibers from amphibole cleavage fragments in fiber counting by phase-contrast microscopy.
Harper M; Lee EG; Slaven JE; Bartley DL
Ann Occup Hyg; 2012 Jul; 56(6):645-59. PubMed ID: 22456032
[TBL] [Abstract][Full Text] [Related]
33. [Pleural mesothelioma and environmental exposure to mineral fibres: the case of a rural area in the Basilicata region, Italy].
Pasetto R; Bruni B; Bruno C; Cauzillo G; Cavone D; Convertini L; De Mei B; Marconi A; Montagano G; Musti M; Paoletti L; Comba P
Ann Ist Super Sanita; 2004; 40(2):251-65. PubMed ID: 15536279
[TBL] [Abstract][Full Text] [Related]
34. Elongate mineral particles in the natural environment.
Gunter ME
Toxicol Appl Pharmacol; 2018 Dec; 361():157-164. PubMed ID: 30291935
[TBL] [Abstract][Full Text] [Related]
35. Characterization of asbestiform glaucophane-winchite in the Franciscan Complex blueschist, northern Diablo Range, California.
Erskine BG; Bailey M
Toxicol Appl Pharmacol; 2018 Dec; 361():3-13. PubMed ID: 30240695
[TBL] [Abstract][Full Text] [Related]
36. Pleural mesothelioma cases in Biancavilla are related to a new fluoro-edenite fibrous amphibole.
Comba P; Gianfagna A; Paoletti L
Arch Environ Health; 2003 Apr; 58(4):229-32. PubMed ID: 14655903
[TBL] [Abstract][Full Text] [Related]
37. Predicting EMP hazard: Lessons from studies with inhaled fibrous and non-fibrous nano- and micro-particles.
Oberdörster G; Graham U
Toxicol Appl Pharmacol; 2018 Dec; 361():50-61. PubMed ID: 29751048
[TBL] [Abstract][Full Text] [Related]
38. A meta-analysis of asbestos-related cancer risk that addresses fiber size and mineral type.
Berman DW; Crump KS
Crit Rev Toxicol; 2008; 38 Suppl 1():49-73. PubMed ID: 18686078
[TBL] [Abstract][Full Text] [Related]
39. Persistent effects of Libby amphibole and amosite asbestos following subchronic inhalation in rats.
Gavett SH; Parkinson CU; Willson GA; Wood CE; Jarabek AM; Roberts KC; Kodavanti UP; Dodd DE
Part Fibre Toxicol; 2016 Apr; 13():17. PubMed ID: 27083413
[TBL] [Abstract][Full Text] [Related]
40. Assessing toxicity of fine and nanoparticles: comparing in vitro measurements to in vivo pulmonary toxicity profiles.
Sayes CM; Reed KL; Warheit DB
Toxicol Sci; 2007 May; 97(1):163-80. PubMed ID: 17301066
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
